Klenprime 60 Clenbuterol

$27.70

SKU: 507 Category:

Manufacturer: Eminence Labs
Substance: Clenbuterol
Package: 60 mcg / tab. (50 tab.)

Description

Description

Klenprime 60: a medicine used in bodybuilding to speed up metabolism and intensely burn excess fat. Observance of a low-calorie diet allows you to accelerate the metabolism to 20-30%. The opinion that the drug has an anabolic effect is incorrect. The anti-catabolic effect of its use is insignificant.

Dosage

The effective dose of Clenbuterol starts from 20 μg / day as the minimum value to 40-140 μg / day and is the maximum dosage. I think it's best to start with 40mcg / day and evaluate the results on an ongoing basis, increasing the dose by 20mcg at a time as needed. Many users adjust the dosage to a level where the hands start shaking, but fat loss can be greatly improved at doses well below this point.

The use of Clenbuterol must be cyclic, rather than used continuously or for long periods of time, but there is no accurate picture of its use. The usage period is typically 2 to 8 weeks. Periods of use, lasting 2 weeks or more at dosages significantly above 40 μg / day, will be less effective. This can be avoided if you drink 1 mg of ketotifen once a day, preferably before breastfeeding.

Side effects

Klenprime 60 has no toxic effects on the kidneys and liver, however it can cause some psychosomatic reactions: tremor, sweating, insomnia, nervous excitement. These effects are either eliminated by Ketotifen or go away on their own after you stop taking it.
Klenprime 60 is a safe and effective weight loss and fat burning product used by athletes to achieve optimal shape. Particularly effective in the preparation phase for competitions.

Effects of admission

  • Acceleration of the body fat removal process
  • Acceleration of metabolism
  • Stimulation of the nervous system
  • Slightly expressed anti-catabolic effect
  • Temperature increase

Reviews

There are no reviews yet.

Be the first to review “Klenprime 60 Clenbuterol”

Your email address will not be published.